World leader in antibacterial & antiviral drug research and development
PIPELINE

About Venatorx Pharmaceuticals

Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.

ABOUT US

Our Culture

Venatorx Named ‘Best Places to Work’ by Philadelphia Business Journal Four Years in a Row
AWARDS
“This is an all-for-one, one-for-all setting. We have had a lot of successes. We’ve had some setbacks. When we face setbacks, we pick ourselves up, we dust ourselves off. We get back into the game. Our team members take a lot of responsibility for what they do here. There isn’t a problem that our team can’t solve.”
Daniel C. Pevear, Ph.D. – Founder and Senior Vice President, Biology and Grants Development
CAREERS

News & Events

Press Releases
May 16, 2024
Venatorx Pharmaceuticals Announces Changes to Executive Leadership
March 12, 2024
Venatorx Pharmaceuticals Expands Senior Leadership Team
In the News
November 11, 2023
Melinta Therapeutics Partnering with Venatorx Pharmaceuticals on Commercializing Antibiotic
Events
IDWeek 2024
Wednesday, October 16, 2024 - Sunday, October 20, 2024
World Melioidosis Congress (WMC) 2024
Monday, October 21, 2024 - Wednesday, October 23, 2024
NEWS & EVENTS
You are using a browser that is not supported. Please consider changing your browser